Compare Novartis AG (NVS) vs J M Smucker Co (SJM) Price & Performance

Novartis AGTrade

J M Smucker CoTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs J M Smucker Co — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while J M Smucker Co trades at $112.69 (market cap $11.97B). The key difference: Novartis AG is far larger — about 24.2× J M Smucker Co's market cap, and J M Smucker Co pays the higher dividend (3.93%). Which is the better fit depends on your goals.

	NVS	SJM
Market Cap	$290.25B	$11.97B
Sector	Health	Consumer Staples
52-Week High	$168.62	$117.05
52-Week Low	$113.50	$89.53
Enterprise Value	$330.27B	$19.00B
Dividend Yield	3.17%	3.93%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 23 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

SJM

Affiliated Managers Group and Madison Square Garden shares rise on strong quarterly resultsSeeking Alpha · 1 day agoBullish J.M. Smucker raises quarterly dividend by 2% to $1.12, marking 25 years of consecutive growth.PRNewsWire · 4 days agoBullish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About J M Smucker Co

J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.